Filing Details
- Accession Number:
- 0001104659-25-011588
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-11 17:58:35
- Reporting Period:
- 2025-02-07
- Accepted Time:
- 2025-02-11 17:58:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806384 | Charles Marlio Mosseri | 27 Ripplevale Grove London N1 1HS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-07 | 240,000 | $5.00 | 2,884,121 | No | 4 | P | Indirect | By Emerald Hill Ventures SARL SPF. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Emerald Hill Ventures SARL SPF. |
Footnotes
- Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
Billionaire Hedge Funds
